Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Big Pharma Pushes Watson's Oxytrol To Specialty Area

This article was originally published in The Pink Sheet Daily

Executive Summary

Continued decline in sales of the overactive bladder patch reinforces Watson focus on the urologist specialty area; firm cites inadequate resources to compete with big pharma in the primary care market.

You may also be interested in...

Watson To Create Brand, Generic Unit Presidents Under Restructuring

The company has initiated an internal and external search to fill the new positions. As part of the reorganization, Watson President and COO Joseph Papa is leaving the company Nov. 19.

Watson Seeks Co-Promotion Partner For Oxytrol In Primary Care Setting

The company is seeking a partner with "strong relationships" with high-volume prescribers of overactive bladder therapies in the primary care market. Watson wants to retain Oxytrol's position in primary care despite the company's intention to shift its marketing focus to specialty care.

NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination

Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts